Weight Gain Clinical Trial
— SNAPOfficial title:
Study of Novel Approaches for Prevention
Verified date | January 2020 |
Source | Wake Forest University Health Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The Study of Novel Approaches for Prevention (SNAP) is randomized trial designed to test
whether behavioral interventions based on self-regulation can prevent weight gain in young
adults (18-35 years; body mass index (BMI) 21-30 kg/m2). Two different self-regulation
interventions for weight gain prevention will be compared in this trial; one intervention
will focus on making small, consistent, changes in eating and exercise behavior to prevent
weight gain or reverse weight gain if it occurs, whereas the other will emphasize larger
changes in eating and exercise that occur periodically, with a goal of producing weight loss
and thereby providing a buffer against anticipated weight gains. The primary aim of the trial
is to test whether the magnitude of weight gain from baseline across an average three-year
follow-up differs across the three groups, with the hypotheses that weight gain will be
greater in the Control group than in either intervention and greater in the Small Changes
than Large Changes group.
SNAP-E (Extension) will determine whether the effects of the intervention can be maintained
over an additional 3 years (i.e. through a total of 6 years).
Status | Completed |
Enrollment | 599 |
Est. completion date | September 30, 2018 |
Est. primary completion date | December 31, 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility |
Inclusion Criteria: 1. BMI of 21 - 30 kg/m2 Exclusion Criteria: 1. Untreated hypertension, hyperlipidemia, or type 2 diabetes, unless permission is provided by their health care provider. 2. Heart disease, heart problems or report being prescribed drugs for blood pressure or a major heart condition, unless permission is provided by their health care provider. 3. Type 1 diabetes or treatment of type 2 diabetes with insulin or oral medication that may cause hypoglycemia. 4. Health problems which may influence the ability to walk for physical activity (e.g. lower limb amputation) or other reasons why a person should not do physical activity, unless permission is provided from their health care provider. 5. Health problems that may be associated with unintentional weight change or affect the safety of a weight loss program, including report of a heart attack or stroke, chest pain during periods of activity or rest, loss of consciousness, active tuberculosis, HIV, chronic hepatitis B or C, inflammatory bowel disease requiring treatment within the past year, thyroid disease, renal disease, liver disease, hospitalization for asthma in the past year, or cancer within the past 5 years (except for non-melanoma skin cancers or early stage cervical cancer) or chronic use of steroid medication. 6. Report of a past diagnosis of or treatment for a Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition-Text Revision (DSM-IV-TR) eating disorder (anorexia nervosa or bulimia nervosa) or meet criteria for anorexia or bulimia nervosa during screening for this trial 7. Report of a past diagnosis of or current symptoms of alcohol or substance dependence. 8. Currently pregnant, pregnant within the past 6 months, or planning to become pregnant within the next 6 months. 9. History of schizophrenia, manic depression, or bipolar disorder. 10. Hospitalization for depression or other psychiatric disorder within the past 12 months. 11. Having lost and maintained a weight loss of 10 pounds or more within the past 6 months or are currently participating in a weight loss program, trying to gain weight, using steroids for muscle mass or weight gain, taking weight loss medication, or have had surgery for weight loss. 12. Participation in another weight loss or physical activity study that would interfere with this study. 13. Another member of the household (or roommate) is a participant or staff member on this trial. 14. Reason to suspect that the participant would not adhere to the study intervention or assessment schedule (i.e., can't come to group on a regular basis; will be away for more than two weeks during initial intervention phase or planning to move from the area within next year). 15. Not able to speak and understand English. 16. Residence or place of work further than 30 miles from the intervention site. 17. Perceived inability to attend the 2 year data collection visit. 18. Does not have Internet access on a regular basis. |
Country | Name | City | State |
---|---|---|---|
United States | University of North Carolina | Chapel Hill | North Carolina |
United States | The Miriam Hospital | Providence | Rhode Island |
Lead Sponsor | Collaborator |
---|---|
Wake Forest University | National Heart, Lung, and Blood Institute (NHLBI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | 6 Year Weight Changes | Changes from baseline to year 6 in body weight | 6 years | |
Primary | Weight Changes From Baseline Over Follow-up. | Mean weight change from baseline across an average planned follow-up of three years. These mean changes will be compared among the three arms of the trial. | 3 years | |
Secondary | Weight Gain 1 Pound or More at Any Time Over Follow-up | Average over time (average follow-up of 3 years) of the percent of participants within each arm of the trial who gain 1 pound or more at each visit. These percentages will be compared among the three arms generalized estimating equations. Note that weight changes in units of pounds were used to define this outcome so that it may be more clear to participants. Elsewhere in the protocol, weight is reported in kilograms. Percentages at each visit are the percent who gained 1 pound or more from baseline among all who were weighed at that visit. Participants were assigned values of 0 or 1 at each visit depending on their weight gain status. | 3 years | |
Secondary | Mean Weight Changes | Mean differences in weight changes among intervention groups at 24 months post-randomization | 2 years | |
Secondary | Mean Changes in Systolic Blood Pressure | Compare changes in systolic blood pressure across the three intervention groups | Measured at 2 Years | |
Secondary | Mean Changes From Baseline in Diastolic Blood Pressure | Change from baseline to 2 years in diastolic blood pressure | 2 years | |
Secondary | Mean Changes From Baseline to 2 Years in Total Cholesterol | Mean changes from baseline to 2 years in total cholesterol among participants with Year 2 measurements (mg/dl) | 2 years | |
Secondary | Obesity | Percentage of those participants whose body mass index at baseline was less than 30 kg/m2 who subsequently transitioned to a body mass index of 30 kg/m2 or more (i.e. met criteria for obesity) sometime during 3 years of follow-up (i.e. at least one visit). Percentages will be compared among the three arms of the trial and summarized with odds ratios Participants were assigned values of 0 or 1 at each exam depending on their obesity level. Inference is based on generalized estimating equations. | 3 years | |
Secondary | Dietary Restraint: Mean Change From Baseline to 2 Years | The Eating Inventory (Stunkard, 1988) is a 51-item self-report instrument, was used to assess the subscale of dietary restraint (e.g., degree of conscious control exerted over eating behaviors; range from 0-21 with higher scores reflecting greater levels of restraint). Reference: Stunkard, A. J. M., S. (1988). Eating Inventory Manual. New York: Psychological Corporation. |
2 years | |
Secondary | Disinhibition | The Eating Inventory (TFEQ(Stunkard, 1988), a 51-item self-report instrument, was used to assess the subscale of disinhibition (e.g., susceptibility to loss of control over eating; range 0-16, with higher scores reflecting greater levels of disinhibition). REF: Stunkard, A. J. M., S. (1988). Eating Inventory Manual. New York: Psychological Corporation. |
Changes at 2 years | |
Secondary | Flexible Dietary Control | Flexible control is characterized by a balanced approach to eating (e.g., taking smaller portions to control weight, engaging in healthy compensation) and is associated with better weight management outcomes (Westenhoefer, Stunkard, & Pudel, 1999). Scores range from 0 to 12 with higher scores reflecting greater levels of flexible control. REF: Westenhoefer, J., Stunkard, A. J., & Pudel, V. (1999). Validation of the flexible and rigid control dimensions of dietary restraint. Int J Eat Disord, 26(1), 53-64. |
Changes from baseline to 2 years | |
Secondary | Rigid Dietary Control | Rigid control is characterized by an all-or-nothing inflexibility around dietary rules (e.g., strict calorie counting, with guilt following if calorie-dense foods are consumed) that is associated with poor weight outcomes and more binge eating (Westenhoefer, Stunkard, & Pudel, 1999). Scores range from 0 to 16 with higher scores reflecting greater rigid control. REF: Stunkard, A. J. M., S. (1988). Eating Inventory Manual. New York: Psychological Corporation. |
Changes from baseline to 2 years | |
Secondary | General Health Index | The General Health Index, a one-item question from the CDC's Health-Related Quality of Life measure (Measuring Healthy Days, 2000) required participants to report whether in general their health is excellent (1), very good (2), good (3), fair (4), or poor (5). Lower scores denotes better outcomes. Ref: Measuring Healthy Days. (2000). Atlanta, Georgia: Centers for Disease Control and Prevention |
Changes from baseline to 2 years | |
Secondary | Mean Changes in High Density Lipoprotein Cholesterol (HDL-C) | Mean changes in HDL-C from baseline to year 2 in (mg/dl) for compared among the 3 arms using analysis of variance | 2 years | |
Secondary | Mean Changes in Low Density Lipoprotein Cholesterol (LDL-C) | Mean changes between baseline and 2 years in low density lipoprotein cholesterol: LDL-c (mg/dl) | 2 years | |
Secondary | Mean Change in Fasting Glucose From Baseline to 2 Years | Mean change in fasting glucose from baseline to 2 years in mg/dl for all participants with year 2 measures | 2 years | |
Secondary | Mean Change in Fasting Insulin From Baseline to 2 Years | Mean change in fasting insulin (uU/ml) from baseline to 2 years | 2 years | |
Secondary | Depression Symptomatology | Mean changes in the Center for Epidemiologic Studies Depression (CES-C) Scale. Reference: Turvey, C. L., Wallace, R. B., & Herzog, R. (1999). A revised CES-D measure of depressive symptoms and a DSM-based measure of major depressive episodes in the elderly. Int Psychogeriatr, 11(2), 139-148. 20 item questionnaire with a possible range of scores is zero to 60, and higher scores indicating the presence of more symptomatology. | 2 years | |
Secondary | Insulin Resistance | We calculated homeostatic model assessment insulin resistance (HOMA-IR): fasting glucose in (mg/dl) * fasting insulin in (uU/mL). | Change from baseline to 2 years | |
Secondary | Total Energy Dietary Intake Per Day (Kcals) | Dietary intake was assessed using the 2005 Block Food Frequency Questionnaire (Block FFQ) at baseline and 2 years. This validated, quantitative 110-food item questionnaire is designed to assess relative intake of energy. REF: Block G, Woods M, Potosky A, Clifford C. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 1990; 43:1327-1335. |
Changes from baseline to 2 years in kilocalories | |
Secondary | Change in Waist Circumference (cm) | Waist circumference will be measured using a Gulik tape measure and following a standardized protocol. Two measures of waist circumference will be taken; if the difference exceeds 1.0 cm, a third measure will be taken. Changes are measured from baseline to year 2. | Change from baseline to 2 years | |
Secondary | Self-weighing | Number of days per week the participant reports weighing themselves. This is divided into two groups: 1) more than once per week and 2) no more than once per week | 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03249896 -
Web/Smartphone-based Lifestyle Coaching Program in Pregnant Women With Gestational Diabetes
|
N/A | |
Recruiting |
NCT04043520 -
Bioenergetic Effects of Aging and Menopause (BEAM)
|
Phase 4 | |
Completed |
NCT05508750 -
Growth and Safety Clinical Trial on a New Infant Formula
|
N/A | |
Not yet recruiting |
NCT03225456 -
Oxytocin and Eating
|
Phase 2 | |
Completed |
NCT02227043 -
Study Of Weight Development Over Time
|
N/A | |
Not yet recruiting |
NCT01916603 -
Diet, Physical Activity and Breastfeeding Intervention on Maternal Nutrition, Offspring Growth and Development
|
N/A | |
Completed |
NCT01958307 -
Healthy Living in Pregnancy
|
N/A | |
Completed |
NCT01693666 -
Lifestyle Intervention Forever: Healthy Weight for Pregnancy and Birth (Pilot Study)
|
N/A | |
Completed |
NCT01461824 -
Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects
|
Phase 3 | |
Terminated |
NCT00759993 -
Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units.
|
Phase 2 | |
Completed |
NCT00634530 -
Impact of a Nutritional Intervention Program for Weight Control During Pregnancy
|
N/A | |
Completed |
NCT00995462 -
Prevention of Weight Gain in University Students
|
N/A | |
Completed |
NCT00122213 -
A Physical Activity and Diet Program to Prevent Accumulation of Abdominal Fat Mass in Recently Retired Men and Women
|
Phase 2 | |
Completed |
NCT00306449 -
Prevention of Weight Gain in Young Adults
|
N/A | |
Completed |
NCT03996551 -
ExeRTiOn2- The Weight Gain Prevention Exercise in Renal Transplant Online Study
|
N/A | |
Recruiting |
NCT03675464 -
Study of Human Adipose Tissue (LOSHAT)
|
||
Completed |
NCT04282655 -
Effect of Milk Warming on the Very Low Birth Weight Infant
|
N/A | |
Recruiting |
NCT05992688 -
The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time)
|
N/A | |
Completed |
NCT04069351 -
Body Composition Changes During Overfeeding Plus Resistance Training
|
N/A | |
Completed |
NCT00687115 -
Predicting Weight Gain and Weight Loss Associated With Overeating or Fasting
|
Phase 2 |